Chemed Corporation $CHE Holdings Raised by Signal Advisors Wealth LLC

Key Points

• Signal Advisors Wealth LLC increased its stake in Chemed Corporation by 49.5%, now owning 9,586 shares valued at approximately $4.67 million after acquiring an additional 3,174 shares.
• Chemed reported Q2 earnings of $4.27 per share, missing estimates by $1.75, while its revenue was $618.80 million, falling short of the forecasted $650.60 million.
• The company declared a quarterly dividend of $0.60, up from the previous $0.50, representing an annualized yield of 0.5% with a payout ratio of 12.34%.

Signal Advisors Wealth LLC grew its stake in Chemed Corporation (NYSE:CHE - Free Report) by 49.5% during the second quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 9,586 shares of the company's stock after purchasing an additional 3,174 shares during the quarter. Signal Advisors Wealth LLC owned approximately 0.07% of Chemed worth $4,667,000 as of its most recent filing with the SEC.

A number of other institutional investors have also modified their holdings of the stock. Bessemer Group Inc. raised its stake in Chemed by 14.2% during the first quarter. Bessemer Group Inc. now owns 950 shares of the company's stock worth $585,000 after acquiring an additional 118 shares during the period. DAVENPORT & Co LLC bought a new position in Chemed in the 1st quarter worth about $265,000. Jump Financial LLC bought a new position in Chemed in the 1st quarter worth about $2,777,000. Mather Group LLC. grew its position in Chemed by 53.3% in the 1st quarter. Mather Group LLC. now owns 161 shares of the company's stock worth $99,000 after purchasing an additional 56 shares during the last quarter. Finally, Park Place Capital Corp grew its position in Chemed by 71.2% in the 1st quarter. Park Place Capital Corp now owns 3,572 shares of the company's stock worth $2,198,000 after purchasing an additional 1,486 shares during the last quarter. Institutional investors and hedge funds own 95.85% of the company's stock.

Chemed Stock Up 0.7%

NYSE:CHE traded up $3.20 during trading hours on Monday, reaching $455.45. 131,595 shares of the company's stock were exchanged, compared to its average volume of 193,580. The company has a market capitalization of $6.64 billion, a P/E ratio of 23.42, a price-to-earnings-growth ratio of 2.63 and a beta of 0.46. Chemed Corporation has a 12 month low of $408.42 and a 12 month high of $623.60. The business's 50-day simple moving average is $450.28 and its two-hundred day simple moving average is $524.60.

Chemed (NYSE:CHE - Get Free Report) last issued its earnings results on Tuesday, July 29th. The company reported $4.27 earnings per share for the quarter, missing analysts' consensus estimates of $6.02 by ($1.75). The business had revenue of $618.80 million for the quarter, compared to the consensus estimate of $650.60 million. Chemed had a return on equity of 25.83% and a net margin of 11.56%.The company's quarterly revenue was up 3.8% on a year-over-year basis. During the same quarter in the previous year, the business posted $5.47 earnings per share. Chemed has set its FY 2025 guidance at 22.000-22.300 EPS. As a group, sell-side analysts anticipate that Chemed Corporation will post 21.43 earnings per share for the current fiscal year.

Chemed Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, August 29th. Investors of record on Monday, August 11th were issued a dividend of $0.60 per share. The ex-dividend date was Monday, August 11th. This is a positive change from Chemed's previous quarterly dividend of $0.50. This represents a $2.40 dividend on an annualized basis and a yield of 0.5%. Chemed's payout ratio is 12.34%.

Wall Street Analysts Forecast Growth

CHE has been the subject of several recent analyst reports. Oppenheimer decreased their target price on shares of Chemed from $650.00 to $580.00 and set an "outperform" rating for the company in a research report on Thursday, July 31st. Bank of America decreased their target price on shares of Chemed from $610.00 to $595.00 and set a "buy" rating for the company in a research report on Wednesday, September 10th. Royal Bank Of Canada decreased their price objective on shares of Chemed from $640.00 to $589.00 and set an "outperform" rating for the company in a report on Thursday, July 31st. Wall Street Zen cut shares of Chemed from a "buy" rating to a "hold" rating in a report on Saturday, July 5th. Finally, Jefferies Financial Group upgraded shares of Chemed from a "hold" rating to a "buy" rating and increased their price objective for the company from $490.00 to $550.00 in a report on Tuesday, September 2nd. Four analysts have rated the stock with a Buy rating, According to MarketBeat, the stock presently has a consensus rating of "Buy" and an average target price of $578.50.

Insider Buying and Selling

In related news, EVP Nicholas Michael Westfall sold 10,012 shares of the firm's stock in a transaction that occurred on Monday, August 4th. The shares were sold at an average price of $421.91, for a total transaction of $4,224,162.92. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Patrick P. Grace sold 150 shares of the company's stock in a transaction that occurred on Tuesday, September 9th. The shares were sold at an average price of $463.39, for a total transaction of $69,508.50. Following the completion of the sale, the director owned 3,397 shares of the company's stock, valued at approximately $1,574,135.83. This trade represents a 4.23% decrease in their position. The disclosure for this sale can be found here. 3.29% of the stock is currently owned by insiders.

Chemed Company Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.